Royal Bank of Canada’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-3,760
| Closed | -$17K | – | 6202 |
|
|
2019
Q1 | $17K | Sell |
3,760
-4,570
| -55% | -$20.7K | ﹤0.01% | 4949 |
|
|
2018
Q4 | $29K | Sell |
8,330
-22,005
| -73% | -$76.6K | ﹤0.01% | 4702 |
|
|
2018
Q3 | $306K | Sell |
30,335
-55
| -0.2% | -$555 | ﹤0.01% | 3654 |
|
|
2018
Q2 | $220K | Sell |
30,390
-2,484
| -8% | -$18K | ﹤0.01% | 3790 |
|
|
2018
Q1 | $199K | Sell |
32,874
-1,955
| -6% | -$11.8K | ﹤0.01% | 3739 |
|
|
2017
Q4 | $335K | Buy |
34,829
+5,727
| +20% | +$55.1K | ﹤0.01% | 3412 |
|
|
2017
Q3 | $258K | Buy |
29,102
+15,407
| +113% | +$137K | ﹤0.01% | 3645 |
|
|
2017
Q2 | $173K | Buy |
13,695
+6,877
| +101% | +$86.9K | ﹤0.01% | 3759 |
|
|
2017
Q1 | $72K | Buy |
6,818
+4,370
| +179% | +$46.1K | ﹤0.01% | 4295 |
|
|
2016
Q4 | $23K | Sell |
2,448
-497
| -17% | -$4.67K | ﹤0.01% | 4948 |
|
|
2016
Q3 | $34K | Buy |
2,945
+662
| +29% | +$7.64K | ﹤0.01% | 4588 |
|
|
2016
Q2 | $29K | Sell |
2,283
-103
| -4% | -$1.31K | ﹤0.01% | 4660 |
|
|
2016
Q1 | $38K | Buy |
2,386
+1,639
| +219% | +$26.1K | ﹤0.01% | 4565 |
|
|
2015
Q4 | $21K | Sell |
747
-1,213
| -62% | -$34.1K | ﹤0.01% | 4950 |
|
|
2015
Q3 | $56K | Sell |
1,960
-8,828
| -82% | -$252K | ﹤0.01% | 4489 |
|
|
2015
Q2 | $387K | Buy |
10,788
+10,598
| +5,578% | +$380K | ﹤0.01% | 3393 |
|
|
2015
Q1 | $6K | Sell |
190
-2,660
| -93% | -$84K | ﹤0.01% | 5252 |
|
|
2014
Q4 | $60K | Sell |
2,850
-1,150
| -29% | -$24.2K | ﹤0.01% | 4405 |
|
|
2014
Q3 | $78K | Buy |
4,000
+800
| +25% | +$15.6K | ﹤0.01% | 4199 |
|
|
2014
Q2 | $50K | Sell |
3,200
-250
| -7% | -$3.91K | ﹤0.01% | 4351 |
|
|
2014
Q1 | $71K | Buy |
3,450
+1,950
| +130% | +$40.1K | ﹤0.01% | 4191 |
|
|
2013
Q4 | $19K | Sell |
1,500
-26,952
| -95% | -$341K | ﹤0.01% | 4653 |
|
|
2013
Q3 | $332K | Buy |
+28,452
| New | +$332K | ﹤0.01% | 3208 |
|